Artiva Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (ARTV)

Q: What does CUSIP 04317A107 represent in this 13F holders report?

CUSIP 04317A107 is the security identifier for ARTV - Artiva Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ARTV - Artiva Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share in Q1 2026?

39 institutional investors reported ARTV - Artiva Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 04317A107

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 16,834,066
Total 13F value: $108,418,693
Share change: -116,140
SEC-reported price per share: $6.44
Number of holders: 39
Value change: -$484,282
Number of buys: 13
Number of sells: 17
Shares outstanding: 48,657,048

Security key

04317A107

Report period

Q1 2026

Institutions

Top holders

ARTV full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Previous quarter: Q4 2025 Artiva Biotherapeutics, Inc. SEC filings Artiva Biotherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 04317A107

Newer quarter: Q2 2026 Previous quarter: Q4 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of ARTV - Artiva Biotherapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

venBio Global Strategic F...

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

10 Mar 2026

13D/G 3/4/5 13F Lead comparable stake: 4.9% 13D/G row: venBio Global Strategic Fund III, L.P. Showing 1-6 of 15 holder rows.

Quick read

venBio Global Strategic Fund III, L.P. leads the comparable SEC ownership view at 4.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens venBio Global Strategic Fund III, L.P.'s linked filing trail.

Comparable ownership Top 5

venBio Global Strategic Fund III,... 4.9%

BlackRock, Inc. 2%

Thad Allen Huston 0.45%

Neha Krishnamohan 0.2%

RA CAPITAL MANAGEMENT, L.P. 20%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
venBio Global Strategic Fund III, L.P.	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	4.9%	$2,937,489 1,198,975 shares	$0	31 Mar 2025
BlackRock, Inc.	13F 13D/G Company 13F 13D/G	2% from 13D/G	$911,788 212,538 shares	—	31 Dec 2025
Thad Allen Huston	3/4/5 Chief Financial Officer 3/4/5	0.45%	$877,800 220,000 shares	—	10 Mar 2026
Neha Krishnamohan	3/4/5 Chief Financial Officer 3/4/5	0.2%	$322,907 99,356 shares	—	15 Nov 2025
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	20%	$42,270,666 9,853,302 shares	—	31 Dec 2025
5AM Venture Management, LLC	13F Company 13F	4.8%	$10,095,674 2,353,304 shares	—	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

16,834,066

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend